CLEVELAND, Oct. 30, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced a presence at upcoming industry functions.
CDISC International Interchange
North Bethesda, Maryland
November 4-8, 2013
Bethesda North Marriott Hotel & Conference Center
DATATRAK will exhibit at the Interchange, displaying the latest upgrades to the DATATRAK ONE™ software suite featuring an unparalleled user configuration. Dr. Bill Gluck, Vice President Clinical and Consulting Services, is a current CDISC Advisory Council (CAC) member, and along with Craig Wigginton, Chief Technology Officer, will participate in the CDISC Advisory Council Meeting on November 5, 2013. The Interchange theme is 'CDISC SHARE - Shared Health And Clinical Research Electronic Library'.
CBI IRT (Interactive Response Technologies) 2013
November 7-8, 2013
Hyatt at the Bellevue
The event will focus on leveraging IWRS for Data Collection, Integration, and Drug Supply Management in Clinical Trials. Niki Kutac, DATATRAK Product Manager, will speak on the Clinical Supply and Inventory Management Session on Friday, November 8th at 10:45am, presenting a case study on Optimizing Supply Strategies Utilizing an IRT System. DATATRAK will exhibit at the event, showcasing the benefits of the DATATRAK ONE™ Software suite, and is proud to be the lanyard sponsor for the event.
Join DATATRAK Thought Leaders:
Tweet: #DATATRAK will be @CDISC @Advanstar_CBI in November. http://bit.ly/1dnW5mH
DATATRAKInternational is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAKONE™ software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on August 12, 2013 announcing its results for the second quarter of 2013. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.